Skip to content

Author

Lan-Xi Hu

We have 1 of 1 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Jul 2026

Research progress on the regulation of mesothelioma driven by deubiquitinating enzyme BAP1.

Clinical and research priorities in elucidating the signaling pathways governed by BAP1, designing targeted therapeutic strategies for BAP1-mutant cancers, and implementing preventive interventions in BAP1 mutation carriers represent urgent clinical and research priorities.

Wan-Ting Xuan, Yao Dong, Sitong Ma et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.